1. Effects of indirubin and isatin on cell viability, mutagenicity, genotoxicity and BAX/ERCC1 gene expression.
- Author
-
Fogaça MV, Cândido-Bacani PM, Benicio LM, Zapata LM, Cardoso PF, de Oliveira MT, Calvo TR, Varanda EA, Vilegas W, and de Syllos Cólus IM
- Subjects
- Animals, Antibiotics, Antineoplastic isolation & purification, Antibiotics, Antineoplastic pharmacology, CHO Cells, Cell Survival drug effects, Cell Survival physiology, Cricetinae, Cricetulus, DNA Damage drug effects, DNA-Binding Proteins genetics, Dose-Response Relationship, Drug, Endonucleases genetics, Female, Gene Expression, HeLa Cells, Humans, Indoles isolation & purification, Indoles pharmacology, Isatin isolation & purification, Male, Mice, Mutagenesis drug effects, Plant Components, Aerial, Plant Extracts isolation & purification, Plant Extracts pharmacology, bcl-2-Associated X Protein genetics, DNA Damage physiology, DNA-Binding Proteins biosynthesis, Endonucleases biosynthesis, Isatin pharmacology, Mutagenesis physiology, bcl-2-Associated X Protein biosynthesis
- Abstract
Context: Indigofera suffruticosa Miller (Fabaceae) and I. truxillensis Kunth produce compounds, such as isatin (ISA) and indirubin (IRN), which possess antitumour properties. Their effects in mammalian cells are still not very well understood., Objective: We evaluated the activities of ISA and/or IRN on cell viability and apoptosis in vitro, their genotoxic potentials in vitro and in vivo, and the IRN- and ISA-induced expression of ERCC1 or BAX genes., Materials and Methods: HeLa and/or CHO-K1 cell lines were tested (3 or 24 h) in the MTT, Trypan blue exclusion, acridine orange/ethidium bromide, cytokinesis-blocked micronucleus (CBMN) and comet (36, 24 and 72 h) tests after treatment with IRN (0.1 to 200 μM) or ISA (0.5 to 50 μM). Gene expression was measured by RT-qPCR in HeLa cells. Swiss albino mice received IRN (3, 4 or 24 h) by gavage (50, 100 and 150 mg/kg determined from the LD
50 - 1 g/kg b.w.) and submitted to comet assay in vivo., Results: IRN reduced the viability of CHO-K1 (24 h; 5 to 200 μM) and HeLa cells (10 to 200 μM), and was antiproliferative in the CBMN test (CHO-K1: 0.5 to 10 μM; HeLa: 5 and 10 μM). The drug did not induce apoptosis, micronucleus neither altered gene expression. IRN and ISA were genotoxic for HeLa cells (3 and 24 h) at all doses tested. IRN (100 and 150 mg/kg) also induced genotoxicity in vivo (4 h)., Conclusion: IRN and ISA have properties that make them candidates as chemotherapeutics for further pharmacological investigations.- Published
- 2017
- Full Text
- View/download PDF